Atorvastatin Calcium
Product Images NDC 68071-4396

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

68071 4396 3

68071 4396 3
Atorvastatin Calcium 10mg tablets label from NuCare Pharmaceuticals, Inc. The label shows a 30 count tablet bottle with each oval white/off-white film-coated tablet engraved with "APO" on one side and "A10" on the other. It includes NDC 68071-4396-3, storage instructions, and FDA reporting information.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line chart compares the cumulative incidence percentages over approximately 3.5 years between Atorvastatin and placebo groups. The y-axis represents cumulative incidence (%) and the x-axis measures time in years. The chart includes a hazard ratio (HR=0.64) with confidence interval (0.50–0.83) and a p-value of 0.0005, indicating statistical comparison between the two groups.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time between Atorvastatin and a placebo. The x-axis represents years up to four years of follow-up, and the y-axis represents cumulative hazard percentage. The graph shows lower cumulative hazard for Atorvastatin compared to placebo over the study period.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing subjects (%) experiencing a cardiovascular event over time (up to 5 years) between two atorvastatin dosage groups: 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes hazard ratio data (HR 0.78) with confidence intervals and a p-value.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of atorvastatin calcium, showing the molecular arrangement and calcium ion association as represented in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.